Lupin bags tentative USFDA nod for Loteprednol Etabonate Ophthalmic Gel Written By Ruchika Sharma10 Jan 2025 11:35 AM ISTLoteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular...
Lupin Pithampur Unit-1 facility gets EIR from USFDA Written By Ruchika Sharma9 Jan 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
Alembic Pharma appoints Prag Goel as Vice President - Sales and Marketing (Megacare, Enteron and Osteofit business divisions) Ruchika Sharma2 Jan 2025 1:04 PM ISTVadodara: Alembic Pharma has announced the appointment of Prag Goel as Vice President - Sales and Marketing (Megacare, Enteron and Osteofit...
Diabetes treatment: Lupin buys Huminsulin from Eli Lilly Written By Ruchika Sharma31 Dec 2024 12:52 PM ISTMumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to further enhance its...
Submit justification for dose assumption and animal toxicity data: CDSCO Panel Tells Lupin on Rizatriptan nasal spray Written By Dr. Divya Colin29 Dec 2024 6:00 PM ISTNew Delhi: Regarding the proposed bioavailability study protocol for Rizatriptan nasal spray (2.5 mg/spray, 5 mg/spray, 7.5 mg/spray), the Subject...
USFDA approves Lupin drug for HIV-1 infection Written By Ruchika Sharma18 Dec 2024 5:11 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA)...
Lupin Digital Health collaborate with Medicover Hospitals for post-discharge cardiac care Ruchika Sharma18 Dec 2024 10:00 AM ISTMumbai: Lupin Digital Health, a wholly owned subsidiary of global pharma major Lupin Limited has announced a transformative collaboration with...
Lupin buys 3 anti-diabetes trademarks from Boehringer Ingelheim Written By Ruchika Sharma14 Dec 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced the acquisition of anti-diabetes trademarks GIBTULIO, GIBTULIO MET and AJADUO from...
Lupin bags tentative USFDA okay for Abacavir, Dolutegravir, Lamivudine Tablets for Oral Suspension for HIV treatment Written By Ruchika Sharma6 Dec 2024 2:56 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
Safety of Lupin's Ranibizumab (Ranieyes) established in Large-Scale Multicenter Study with 2194 injections in 1401 eyes Written By Dr. Nandita Mohan6 Dec 2024 12:19 PM ISTReal-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) is a safe...
Cipla appoints Girish Verulkar as Director - Human Resources Ruchika Sharma5 Dec 2024 4:46 PM ISTMumbai: Pharma giant, Cipla, has appointed Girish Verulkar as Director - Human Resources.In a LinkedIn post, Girish shared, "I’m happy to share...
Lupin RnD facility in Pune bags LEED Platinum Certification Ruchika Sharma5 Dec 2024 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced that its R&D facility at Lupin Research Park, Pune has been awarded the LEED Platinum...
